Decree of the Ministry of Health of the Czech Socialist Republic No. 75 / 1986 Coll.
Decree of the Ministry of Health of the Czech Socialist Republic, implementing the Act of the Czech National Council No. 66 / 1986 Coll., on artificial abortion
Valid
Effective from 01.01.1987
Zobrazeno prvních 200 z celkem 306 ustanovení tohoto předpisu.
Zobrazit celý předpis →
Pro stažení celého znění použijte tlačítko Stáhnout výše.
75
DECLARATION
Ministry of Health of the Czech Socialist Republic
of 7 November 1986
implementing the Act of the Czech National Council No. 66 / 1986 Coll., on artificial abortion
The Ministry of Health of the Czech Socialist Republic provides, pursuant to Section 12 of the Act of the Czech National Council No. 66 / 1986 Coll., on the artificial interruption of pregnancy:
Conditions for abortion
Health reasons for which pregnancy cannot be artificially interrupted at the request of a woman (contraindications) shall be considered as:
(a) the state of health of a woman who substantially increases the health risk associated with abortion, in particular inflammatory diseases,
(b) artificial discontinuation of a pregnancy from which six months have not elapsed, except where:
1. a woman gives birth at least twice; or
2. the woman has reached 35 years of age; or
3. It is reasonable to suspect that a woman has become pregnant as a result of the crime committed against her.
(1) The list of diseases, syndromes and conditions which are medical grounds for abortion is set out in the Annex to this Decree. After 12 weeks of pregnancy, pregnancy may be artificially interrupted only if the life of a woman is at risk or there is evidence of severe harm to the foetus or if the foetus is unfit for life.
(2) If there are genetic grounds for artificial abortion, pregnancy may be artificially interrupted until 24 weeks of pregnancy at the latest.
(1) For health reasons, a woman, with her consent, shall be artificially interrupted if the health care institution has given the initiative to do so, or if the health reason has been confirmed.
(2) Health reasons for abortion are entitled to be assessed by the head of the department of the medical institution in whose field the disease belongs or by his authorised representative.
(3) If the health care institution has given the initiative to stop pregnancy artificially and the woman refuses to give her consent, a written statement (reverse) shall be made by the woman who refuses to stop pregnancy artificially.
Procedure for dealing with abortion
(1) A female healthcare professional responsible for the place of permanent residence of a woman or of her workplace or school (hereinafter referred to as "doctor"), who has been requested in writing by a woman to have an abortion, to examine the woman, determine the duration of pregnancy, establish whether artificial abortion does not prevent health reasons (contraindications) and conclude. The duration of pregnancy is calculated in completed weeks starting on the first day of the last period. The woman shall confirm in writing to the healthcare institution that the doctor has informed her of her conclusion and that she has informed her of the possible health consequences of the abortion, as well as of the methods of use of contraceptive methods and devices (1).
(2) For the submission of an application for abortion and follow-up, a claim for abortion and abortion form shall be used, (2) for the examination of the conclusions of the physician, a claim for examination of the conclusion of the physician shall be used. 3) These forms will be given to the woman by the doctor.
(3) A woman may withdraw her application or consent until the performance of the abortion. This will be indicated by the doctor in the woman's medical file.
(1) The consent of the legal representative or, where appropriate, of the person to whom he or she has been assigned to education (hereinafter referred to as "legal representative") is required for the consent of the legal representative, also for the artificial cessation of pregnancy, for health reasons.
(2) If the consent of the legal representative is necessary for the artificial interruption of pregnancy, its consent shall be indicated in the medical file.
Place of performance of abortion, reporting and duty of health workers
(1) The doctor or, where appropriate, a district or county specialist in the field of gyno and obstetrics, who has examined the conclusion of the doctor, will determine, for the performance of the artificial interruption of pregnancy ("performance"), the withdrawal medical establishment of the hospital. At the request of a woman, it may also identify other health care facilities for constitutional care, if that institution agrees.
(2) The medical establishment shall perform the performance without delay; inform the woman of the time of execution when submitting her application with the conclusion of the doctor or of the person who examined the conclusion.
(3) At the request of a woman of 16 to 18 years of age, she shall inform the health care institution of her legal representative immediately after performance by means of an appropriate oral or written notification.
A medical institution in which pregnancy has been artificially interrupted shall submit this by the fifth day of each month (2) to the Regional Institute of National Health for Statistical Processing. Similar reports are sent to the district specialist for gyno and obstetrics responsible according to the woman's permanent residence.
All participating workers shall be obliged to remain silent about the facts they have learned in connection with the abortion of pregnancy and to conserve the legitimate interests of the woman.
Artificial abortion to foreigners
(1) The residence of foreigners who work in bodies and organisations based in the Czech Socialist Republic, or members of the families of the workers of these institutions and organisations, the residence of students and other foreigners who have a residence permit for foreigners under special regulations, is not considered to be transitional. The medical establishment shall be obliged to require the production of the relevant document. 8)
Repeal
The Decree of the Ministry of Health of the Czech Republic of 26 May 1977 No. LP / 2251-10.5.1977 No. 3 / 1977 MZ CSR on payment for examination and control of hormonal and intrauterine contraception, registered in the amount of 2 / 1978 Coll.
Efficacy
This decree shall take effect on 1 January 1987.
Minister:
Prof. MUDr. Prohill CSc. v. r.
Annex to Decree No 75 / 1986 Coll.
List of diseases, syndromes and conditions that are medical grounds for abortion
1. Internal
(a) heart and vascular disease
Chlopenic defects, in particular mitral and aortic stenosis, with limited cardiac performance or one that experienced pre-pregnancy signs of circulatory weakness, heart attack, major circulation emboli or acute pulmonary oedema. Acute or evolutionary inflammatory heart disease (myocarditis, infectious endocarditis, rheumatic fever).
Heart muscle infections.
Any cardiac disease that occurs by the end of the 12th week of pregnancy is arrhythmias (atrial agitation or agitation, cardiac syncope), venous congestive or cyanosis.
Congenital heart defects with disorders of the circulation of the blood, in particular those with cyanosis and coarctation of the aorta with a clear overpressure on the upper extremities.
Conditions after heart surgery and large blood vessels for congenital or acquired heart defects, unless a complete correction of the defect and normalisation of haemodynamic ratios has been achieved.
Hypertension resistant to treatment with high diastolic pressure.
Variation complex of large degree, especially affecting the landscapes of birth and lower extremities, with ulcerations and thrombophlebitis.
Diagnotically safely proven cardiomyopathy.
For lighter heart disease, which does not show signs of progression, it should be considered whether the mother will be able to protect herself sufficiently (household, employment, nursing especially in the first 2-3 years, if there are more young children in the family needed supervision even at night).
(b) lung disease
Pulmonary diseases with reduced respiratory function (pulmonary insufficiency, bronchiectasis, chronic bronchitis, emphysis).
Chronic pulmonary infection.
(c) kidney disease
Chronic glomerulonephritis, particularly with signs of active inflammatory process.
Chronic glomerulonephritis accompanied by nephrotic or hypertensive syndrome.
Pyelonephritis with limited renal function.
Nephrotic syndrome.
Polycystic kidneys.
Genetically contingent nephropathy (e. g. metabolic tubular syndromes), any kidney disease where glomerular filtration is permanently below 50%.
(d) disease of blood production
Bleeding diseases where severe bleeding can be expected at birth and in six weeks.
All hemoblastosis and hemoblastoma.
Myeloproliferative states.
Hemolytic anemia.
Proven transfer of severe forms of haemophilia or of the disease of Rendua - Oslerova - Weber.
(e) digestive tract diseases
Complicated cholelithiasis (biliary cirrhosis, choledocholithiasis, gallbladder empyme, cholangitis, pancreatitis).
Recurrent pancreatitis, pancreatitis.
Active or prolonged recurrent gastroduodenal ulcerative disease
Haematological (ulcerative) proctocolitis and regional enterocolitis (Crohn 's disease).
Stages of detectable denutrice caused by digestive diseases.
Chronic parenchymatous liver disease.
Post-infectious hepatitis status up to 1 year with signs of hepatic impairment.
(f) endocrine disorders
Basedown disease.
Struma with mechanical consequences especially retrosternal strum with compression of cervical veins.
Hyperthyroidism - metabolic unstable (all forms).
Uncompensated hypothyroidism.
Hyperparat hyroidism.
Adenomas of the adrenal gland.
Feochromocytoma.
Type I diabetes mellitus if the diabetic was not ideally compensated during conception or during the first weeks of pregnancy.
Diabetes mellitus type I with complications (especially vascular), in juvenile forms in abortions and death of the fetus, but also diabetes mellitus (juvenile type) without complications.
Diabetes mellitus type II, where pregnancy can be expected to worsen the underlying disease.
Diabetes mellitus type II with complications (especially vascular, cardiovascular).
Diabetes mellitus type I and II at bilateral loads (diabetes of both parents or in both families).
Gestational diabetes during a previous pregnancy (requiring insulin administration), if other risk factors are present, especially a genetic burden.
In all cases of diabetes I, II and gestational DM, where evidence of HbA1c or other long-term compensation indicator has been shown to be poor compensation at the time of conception (HbA1c level, above 10%).
Other endocrinopathy based on an examination of the institute.
(g) infectious diseases
During the disease: safely proven teratogenicity or other risk to the foetus such as rubella, cytomegalovirus infection, toxoplasmosis, varicella, AIDS is possible to interrupt in collaboration with the genetic department until 24 weeks of pregnancy. Infections with possible teratogenicity or other potential risks to the foetus such as mumps, herpes simplex, EB virosa, coxsackiosis B, influenza with temperatures of 40 ° C or more, lymphocytic choriomeningitis, parvovirosa, viral hepatitis (especially type B), listeriosis and administration of live vaccines to the mother.
(h) metabolic disorders
Repeated-seizure days or patients systematically treated for this disease.
Lipid metabolism disorders biochemically proven, in particular genetically contingent or with signs of organ subsequent changes (e. g. arteriosclerosis).
Thesaurismoses proven histologically or biochemically.
2. Surgical
Extensive abdominal hernia, diaphragm and hiat hernia, if the woman disagrees with surgery.
Post-stress syndrome after gastric resection and postcholecystectomy syndrome.
Recurrent ileus.
Surgically treated congenital anomalies of the colon and rectum.
Extensive benign abdominal and pelvic tumors.
Lung resection states with a reduction in lung capacity.
Lung actinomycosis and pulmonary abscesses.
Advanced organic changes in peripheral vessels.
Right and wrong arteriovenous aortic aneurysms of aorta and large vessels of intra-abdominal and limb.
Malformation of brain vessels anatomically benign.
3. Urological
Conditions after kidney removal, or if one kidney is missing (agenesis) or is atrophied (hypoplasia) in case of functional insufficiency of the remaining kidney.
Kidney cystitis.
Pyelonephritis with limited renal function.
Haematuria from unknown causes.
Nephrolithiasis is bilateral, although the details are not fixed and often spontaneously leave both kidneys - urate urolithiasis.
Papillomatosis of the bladder.
Hydronephrosis.
Other severe developmental abnormalities leading to decreased kidney function.
4. Orthopaedic
All hereditary birth defects of the osteoarticular apparatus.
Stations to congenital hip dysplasia from subluxation above.
The state after Perthes' disease followed by prearthrosa.
Juvenile epiphyzeolysis states of the femur head.
Spondylolysa, spondylolistesa.
Scoliosis of the thoracic and lumbar spine above 30 st
Pelvic deformities (hypoplasia)
obtained (post-stradiation, Crobak's pelvis, etc.)
PTSD.
Deformation arthritis of carrier joints.
Construction after extensive and complicated fractures with functional or anatomical defect.
Juvenile rheumatoid arthritis, progressive chronic polyarthritis.
Severe walk stereotype disorders.
Ankylosing large joints.
Post-traumatic conditions accompanied by paresis of large peripheral nerves.
Systemic diseases, metabolic osteopathy.
Poliomyelitis states.
Child's cerebral palsy.
Recurrent chronic osteomyelitis.
Tumours of the musculoskeletal system and similar malignant effects, potentially malignant, recurring or causing problems as a result of localisation.
5. Revmatological
Spondylarthritis ankylosing - Morbus Bechvorev.
Polyarthritis progressive "rheumatoid arthritis."
In chronic polyarthritis, account should be taken in particular of the course of the disease, its activity and its effect on treatment, as well as its performance.
Chronic gout with advanced deformations and especially visceral (renal) disorders.
Rheumatic fever at activity stage and penicillin prevention time.
Confusion disease (called collagenosis)
a) systemic lupus erythematosus, especially evolutionary forms with lupus symptoms, nephritis,
(b) sclerodermia diffusa, particularly progressive forms with signs of organ involvement,
(c) dermatomyosa with polymyositic syndrome and visceral changes,
(d) nodosis polyarteritis.
6. Oncological
(a) malignant neoplasms and conditions after removal by surgery or treatment of radiation which may adversely affect pregnancy, affect the fetus or threaten a woman in a state of health;
(b) carcinoma in situ if the mother's health is at risk.
7. Tyres
Tubericide and other mycobacteriosis
(a) Tubericide and other mycobacteriosis of the respiratory tract
All forms of tuberculosis or other mycobacteriosis in the evolutionary phase (disintegration, sowing, infiltration) with or without mycobacteria found, although despite treatment with antituberculosis, pregnancy can be expected to worsen the disease of the future mother.
All forms of tuberculosis or other mycobacteriosis in resorption or inactive form:
- with substantially reduced cardiac respiratory function due to underlying illness
- complicated other serious diseases, although the degree of pregnancy itself is not an indication for abortion (e. g. diabetes mellitus).
- if pregnancy has had an effect on the worsening of tuberculosis.
Infectious forms of tuberculosis in people living in the same household with their mother-to-be who cannot be negatized by anti-tuberculosis treatment and cannot be isolated.
(b) Non-pulmonary tuberculosis
Renal tuberculosis with significant loss of renal parenchymal and chronic renal insufficiency.
Post-tuberculosis nephropathy for which pregnancy could lead to decompensation.
Florida specific cystitis in renal tuberculosis, which persists despite treatment with antituberculosis and induces functional changes.
Non-specific lung and pleural diseases
All lung diseases, complicated by limiting cardiac respiratory function, which is crucial to the indication to stop pregnancy. Such restrictions may give rise in particular to the following diseases:
- chronic obstructive lung disease (chronic bronchitis, bronchiale asthma, emphysis, bronchiectasia)
- extensive sarcoidosis
- pneumoconiosis
- diffuse pulmonary fibrosis and allergic alveolitis
- large pleural joints.
Chronic inflammatory lung disease (e. g. pulmonary abscess, bronchiectasia).
8. Neurological
Multiple sclerosis of cerebrospinal and other demyelinating diseases (depending on the severity of the condition and picture of the disease).
Paraplegia and severe paraparesis of the lower limbs for organic causes.
Brain tumors, spinal cord and their packaging.
Parasitic diseases of the central nervous system.
Degenerative and hereddegenerative diseases of the central nervous system (e.g. Friedreichova disease, Pierre-Marierova disease, Wilson's disease, Westphal-Strümpell disease, Creutzfeldova-Jakob disease, Alshemarova disease, Gerstmmenova disease, Sträussler sy., amyotrophic lateral sclerosis).
All myopathy.
Dystrophic myotonia.
Sign in for notes, favorites and notifications
Regulation Information
| Citation | Decree of the Ministry of Health of the Czech Socialist Republic No. 75 / 1986 Coll., implementing the Act of the Czech National Council No. 66 / 1986 Coll., on artificial abortion |
|---|---|
| Regulation Type | - |
| Author | - |
| Collection | Code of Laws |
| Date of Promulgation | 28.11.1986 |
|---|---|
| Effective from | 01.01.1987 |
| Effective until | - |
| Status | Valid |
The regulation text is for informational purposes only.
Comments 0